• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素-γ:抗击乙肝病毒感染的关键因素?

IFN-γ: A Crucial Player in the Fight Against HBV Infection?

作者信息

Hillaire Marine Laure Bettina, Lawrence Philip, Lagrange Brice

机构信息

Confluence: Sciences et Humanités (EA 1598), Université Catholique de Lyon, Lyon, France.

出版信息

Immune Netw. 2023 Jun 15;23(4):e30. doi: 10.4110/in.2023.23.e30. eCollection 2023 Aug.

DOI:10.4110/in.2023.23.e30
PMID:37670813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10475827/
Abstract

About 0.8 million people die because of hepatitis B virus (HBV) infection each year. In around 5% of infected adults, the immune system is ineffective in countering HBV infection, leading to chronic hepatitis B (CHB). CHB is associated with hepatocellular carcinoma, which can lead to patient death. Unfortunately, although current treatments against CHB allow control of HBV infection, they are unable to achieve complete eradication of the virus. Cytokines of the IFN family represent part of the innate immune system and are key players in virus elimination. IFN secretion induces the expression of interferon stimulated genes, producing proteins that have antiviral properties and that are essential to cell-autonomous immunity. IFN-α is commonly used as a therapeutic approach for CHB. In addition, IFN-γ has been identified as the main IFN family member responsible for HBV eradication during acute infection. In this review, we summarize the key evidence gained from cellular or animal models of HBV replication or infection concerning the potential anti-HBV roles of IFN-γ with a particular focus on some IFN-γ-inducible genes.

摘要

每年约有80万人死于乙型肝炎病毒(HBV)感染。在约5%的成年感染者中,免疫系统无法有效对抗HBV感染,从而导致慢性乙型肝炎(CHB)。CHB与肝细胞癌相关,可导致患者死亡。不幸的是,尽管目前针对CHB的治疗能够控制HBV感染,但无法实现病毒的完全清除。IFN家族的细胞因子是固有免疫系统的一部分,是病毒清除的关键参与者。IFN分泌诱导干扰素刺激基因的表达,产生具有抗病毒特性且对细胞自主免疫至关重要的蛋白质。IFN-α通常用作CHB的治疗方法。此外,IFN-γ已被确定为急性感染期间负责清除HBV的主要IFN家族成员。在本综述中,我们总结了从HBV复制或感染的细胞或动物模型中获得的关于IFN-γ潜在抗HBV作用的关键证据,特别关注一些IFN-γ诱导基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/10475827/ebf121cb0032/in-23-e30-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/10475827/5228d0444731/in-23-e30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/10475827/ebf121cb0032/in-23-e30-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/10475827/5228d0444731/in-23-e30-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae0/10475827/ebf121cb0032/in-23-e30-g002.jpg

相似文献

1
IFN-γ: A Crucial Player in the Fight Against HBV Infection?干扰素-γ:抗击乙肝病毒感染的关键因素?
Immune Netw. 2023 Jun 15;23(4):e30. doi: 10.4110/in.2023.23.e30. eCollection 2023 Aug.
2
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.基质金属蛋白酶9通过与I型干扰素(IFN)受体1结合以抑制IFN/JAK/STAT信号传导来促进乙型肝炎病毒复制。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.01824-16. Print 2017 Apr 15.
3
Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study.在一项Ib/IIa期研究中,治疗性疫苗BRII-179可恢复慢性乙肝患者的乙肝病毒特异性免疫反应。
JHEP Rep. 2021 Sep 8;3(6):100361. doi: 10.1016/j.jhepr.2021.100361. eCollection 2021 Dec.
4
Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.在水动力注射小鼠模型中,聚肌胞苷酸(Poly(I:C))治疗可导致乙型肝炎病毒通过干扰素依赖性方式清除。
J Virol. 2014 Sep;88(18):10421-31. doi: 10.1128/JVI.00996-14. Epub 2014 Jun 11.
5
Update on hepatitis B virus infection.乙型肝炎病毒感染的最新情况。
World J Gastroenterol. 2014 Oct 7;20(37):13293-305. doi: 10.3748/wjg.v20.i37.13293.
6
Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.Toll 样受体 7 激动剂 GS-9620 通过 I 型干扰素依赖机制诱导乙型肝炎病毒的长期抑制。
J Hepatol. 2018 May;68(5):922-931. doi: 10.1016/j.jhep.2017.12.007. Epub 2017 Dec 13.
7
Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.树突状细胞培养物和肝脏细胞胞质 DNA 感应受体的激动剂激活诱导抗病毒作用。
Front Immunol. 2021 Oct 4;12:745802. doi: 10.3389/fimmu.2021.745802. eCollection 2021.
8
Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.慢性乙型肝炎感染不同阶段中 MDSC 的多方面表现:对 HBV 特异性 T 细胞应答和归巢的影响。
Hepatology. 2022 Sep;76(3):759-774. doi: 10.1002/hep.32331. Epub 2022 Feb 28.
9
Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.未治疗的慢性乙型肝炎患者固有和适应性免疫反应细胞因子谱与临床病毒学特征的关系。
BMC Infect Dis. 2020 Jul 14;20(1):509. doi: 10.1186/s12879-020-05233-x.
10
Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.色氨酸 2,3-双加氧酶介导γ干扰素对人源性肝细胞中乙型肝炎病毒的抗病毒作用。
J Virol. 2011 Jan;85(2):1048-57. doi: 10.1128/JVI.01998-10. Epub 2010 Nov 17.

引用本文的文献

1
Interferon in Liver Diseases: Recent Advances.肝脏疾病中的干扰素:最新进展
Adv Ther. 2025 Jul 17. doi: 10.1007/s12325-025-03291-8.
2
Viral-Track integrated single-cell RNA-sequencing reveals HBV lymphotropism and immunosuppressive microenvironment in HBV-associated hepatocellular carcinoma.Viral-Track整合单细胞RNA测序揭示了乙肝病毒相关肝细胞癌中的乙肝病毒嗜淋巴细胞性和免疫抑制微环境。
Commun Biol. 2025 Jul 9;8(1):1030. doi: 10.1038/s42003-025-08443-8.
3
Non-parenchymal cells: key targets for modulating chronic liver diseases.非实质细胞:调节慢性肝病的关键靶点。

本文引用的文献

1
Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects.基于寡核苷酸的慢性乙型肝炎病毒感染治疗:生物化学、作用机制和抗病毒作用简介。
Viruses. 2022 Sep 16;14(9):2052. doi: 10.3390/v14092052.
2
The therapeutic effect of IL-21 combined with IFN-γ inducing CD4CXCR5CD57T cells differentiation on hepatocellular carcinoma.IL-21联合IFN-γ诱导CD4CXCR5CD57T细胞分化对肝细胞癌的治疗作用
J Adv Res. 2021 Jun 1;36:89-99. doi: 10.1016/j.jare.2021.05.010. eCollection 2022 Feb.
3
Advances in human monoclonal antibody therapy for HBV infection.
Front Immunol. 2025 Jun 11;16:1576739. doi: 10.3389/fimmu.2025.1576739. eCollection 2025.
4
HLA-DR⁺ Tumor Cells Show an Association with a Distinct Immune Microenvironment and CD8⁺ T-Cell Exhaustion in HBV-Associated Hepatocellular Carcinoma.HLA-DR⁺肿瘤细胞与乙肝相关肝细胞癌中独特的免疫微环境及CD8⁺T细胞耗竭相关。
Adv Sci (Weinh). 2025 Aug;12(30):e02979. doi: 10.1002/advs.202502979. Epub 2025 Jun 4.
5
Chronic Hepatitis B Virus Persistence: Mechanisms and Insights.慢性乙型肝炎病毒持续感染:机制与见解
Cureus. 2025 Feb 13;17(2):e78944. doi: 10.7759/cureus.78944. eCollection 2025 Feb.
6
Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection.乙肝病毒和丙肝病毒感染导致的微生物群失调会在感染病理生物群中诱导细胞因子谱改变。
Braz J Infect Dis. 2025 Jan-Feb;29(1):104468. doi: 10.1016/j.bjid.2024.104468. Epub 2024 Nov 28.
7
Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation.自然杀伤细胞对乙型肝炎病毒感染的细胞因子反应取决于单核细胞共刺激。
Viruses. 2024 May 8;16(5):741. doi: 10.3390/v16050741.
8
Altered gut microbiota is associated with the formation of occult hepatitis B virus infection.肠道微生物群的改变与隐匿性乙型肝炎病毒感染的形成有关。
Microbiol Spectr. 2024 Jul 2;12(7):e0023924. doi: 10.1128/spectrum.00239-24. Epub 2024 May 24.
9
Intranasal Immunization With Nanoparticles Containing an Protein Vaccine Candidate and a Polysorbitol Transporter Adjuvant Enhances Both Humoral and Cellular Immune Responses.用含有一种候选蛋白质疫苗和一种聚山梨醇转运体佐剂的纳米颗粒进行鼻内免疫可增强体液免疫和细胞免疫反应。
Immune Netw. 2023 Dec 15;23(6):e47. doi: 10.4110/in.2023.23.e47. eCollection 2023 Dec.
10
Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression.动粒支架蛋白1(KNL1)在泛癌发生及肿瘤免疫微环境中的作用:生物信息学分析与表达验证
Int J Gen Med. 2023 Oct 31;16:4883-4906. doi: 10.2147/IJGM.S424245. eCollection 2023.
HBV 感染的人源单克隆抗体治疗进展。
Curr Opin Virol. 2022 Apr;53:101205. doi: 10.1016/j.coviro.2022.101205. Epub 2022 Feb 2.
4
Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV).干扰素-γ(IFN-γ)基因多态性(+874A/T 和 +2109A/G)与乙型肝炎病毒感染(HBV)易感性的关系。
J Appl Biomed. 2022 Mar;20(1):37-43. doi: 10.32725/jab.2022.001. Epub 2022 Jan 12.
5
The Characteristics of Natural Killer Cells and T Cells Vary With the Natural History of Chronic Hepatitis B in Children.自然杀伤细胞和T细胞的特征随儿童慢性乙型肝炎的自然病程而变化。
Front Pediatr. 2021 Nov 25;9:736023. doi: 10.3389/fped.2021.736023. eCollection 2021.
6
Inhibition of PKR by Viruses.病毒对蛋白激酶R的抑制作用。
Front Microbiol. 2021 Oct 25;12:757238. doi: 10.3389/fmicb.2021.757238. eCollection 2021.
7
IFN-γ facilitates liver fibrogenesis by CD161CD4 T cells through a regenerative IL-23/IL-17 axis in chronic hepatitis B virus infection.在慢性乙型肝炎病毒感染中,干扰素-γ通过CD161⁺CD4⁺ T细胞经再生性白细胞介素-23/白细胞介素-17轴促进肝纤维化形成。
Clin Transl Immunology. 2021 Nov 2;10(11):e1353. doi: 10.1002/cti2.1353. eCollection 2021.
8
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.在慢性乙型肝炎患者中,反义寡核苷酸药物 bepirovirsen 的安全性、耐受性和抗病毒活性:一项 2 期随机对照试验。
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4. Epub 2021 Oct 12.
9
Interferon and Hepatitis B: Current and Future Perspectives.干扰素与乙型肝炎:现状与未来展望。
Front Immunol. 2021 Sep 7;12:733364. doi: 10.3389/fimmu.2021.733364. eCollection 2021.
10
Human APOBEC3 Variations and Viral Infection.人类 APOBEC3 变异与病毒感染。
Viruses. 2021 Jul 14;13(7):1366. doi: 10.3390/v13071366.